We are Virvio | Minibinders | Innovative | Medicines

Virvio designs innovative medicines that improve people's lives. Our computational drug discovery platform rapidly optimizes synthetic biotherapies that are easy to manufacture, shelf stable and outperform known antibodies.

Our Minibinders Get In Touch
Come learn about Virvio

Minibinder Medicines

Virvio is changing how ordinary people get treated for common diseases. Our minibinder medicines mimic proven monoclonal antibodies with safer, more effective biologic alternatives. These medicines represent a new era of accessible treatments for indications like asthma, flu and neuropathic pain.

Old Antibody Interaction

Traditional monoclonal antibodies have proven effects but also many well-known limitations. They are relatively clumsy by today’s biotechnology standards and can have serious toxicity issues compared to alternative biotherapeutics.

New Minibinder Interaction

Virvio minibinders confer the same advantages as traditional biologics. Unlike other biologics, our design algorithms are also able to tailor scaffold characteristics and structures that are unattainable with other methods.

The Virvio difference - in 60 Seconds

We are proud of these

Amazing Numbers

> 700
Scaffolds made
~ 1 nM
Affinity to target
Months per lead
Cost per lead

Want more info on our anti-flu minibinder?

We truly appreciate these

Great Partners

Here is some important

Virvio News

Research – Designer Minibinder Scaffolds

Virvio co-founders publish Science article- Dr. Aaron Chevalier and Prof. David Baker have co-authored a new article in Science describing the design and selection process for the de novo scaffolds …

Event – Hello Tomorrow Challenge

Top 500 Startups @ Hello Tomorrow Challenge – Virvio and its minibinder discovery technology has been named one of the Top 500 Startups in the world by the Hello Tomorrow …

Press Coverage – Protein Origami

NOVA – The Origami Revolution – Virvio co-founders Dr. Aaron Chevalier and Prof. David Baker featured in an episode of NOVA, including a description of our anti-flu minibinder. (http://www.pbs.org/wgbh/nova/physics/origami-revolution.html)